자궁경부이형성 시장 : 진단 유형별, 최종사용자별, 지역별

Global Cervical Dysplasia Market is estimated to be valued at USD 822.2 Mn in 2025 and is expected to reach USD 1,364. Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.

Figure. Cervical Dysplasia Market Share (%), By Region 2025

Cervical dysplasia is precancerous changes of the cells that make up the lining of the cervix, the opening to the womb (uterus). These changes are detected by microscopic analysis of cell samples which are taken from the cervix during a pelvic exam. Squamous intraepithelial lesion is the pathology term that is used to refer to cervical dysplasia which is observed in smears of cells taken from the cervix. Cervical dysplasia is caused by infection with the human papillomavirus (HPV). HPV is a very common infection that is transmitted through sexual contact. Most new HPV infections occur in young (ages 15-25) women. Most HPV infections do not produce any symptoms and resolve spontaneously.

Market Dynamics:

Increasing organic strategies by the key market players is expected to drive the market growth over the forecast period. For instance, on March 1, 2021, INOVIO, a biotechnology company focused on bringing to market precisely designed deoxyribonucleic acid (DNA)medicines to treat and protect people from infectious diseases, cancer and HPV-associated diseases, announced that it met primary and secondary endpoints among all evaluable subjects for the REVEAL 1 trial. This trial is one of two ongoing pivotal, randomized, double-blind, multi-center, placebo-controlled, Phase 3 trials evaluating the safety, tolerability, and efficacy of VGX-3100 to treat HPV-16/18-associated cervical high-grade squamous intraepithelial lesions (HSIL) using the company's proprietary CELLECTRA 5PSP device.

Cervical Dysplasia Market Detailed Segmentation:

• By Diagnosis Type
  • Diagnosis Test
  • HPV Test
  • Pap Smear Test
  • Biopsy Test
  • Diagnostic Device
  • Colposcope
• By End User
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Roche
  • Qiagen
  • Abbott Laboratories
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Diagnosis Type
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing government initiatives
• Growing prevalence of cervical dysplasia globally
  • Restraints
• Lack of awareness in developing nations
  • Opportunities
• Increasing government funding
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions and Collaborations

4. Cervical Dysplasia Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Cervical Dysplasia Market, By Diagnosis Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Diagnosis Test
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• HPV Test
• Pap Smear Test
• Biopsy Test
• Diagnostic Device
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Colposcope

6. Cervical Dysplasia Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Ambulatory Surgery Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Cervical Dysplasia Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2025and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Company Profile
  • Roche
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Qiagen
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Abbott Laboratories
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical
  • Analyst Views

9. Section

• References
• Research Methodology
• About us